NCT03321981 2024-03-07MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.Merus B.V.Phase 2 Completed105 enrolled 23 charts